AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Financial Results | Balchem 2025 Q1 Revenue USD 250.52 Million Net Income USD 37.05 Million
ByAinvest
Friday, Apr 25, 2025 4:00 am ET1min read
Balchem(BCPC) posted the Q1 of its 2025 financial results on 4/24/2025, reporting total revenue of USD 250.52 million in the first quarter, up 4.53% from USD 239.66 million year over year, reporting net income of USD 37.05 million in the first quarter, up 27.83% from USD 28.99 million year over year. The EPS is USD 1.14 in the frist quater, compare with USD 0.9 last period.
[Detailed Data]
| Million USD | Q1 2025 | Q4 2024 | Q3 2024 | Q4 2024 |
|---|---|---|---|---|
| Total Revenue | 250.52 | 240.00 | 239.94 | 240.00 |
| Cost of Sales | 162.35 | 153.67 | 154.58 | 153.67 |
| Gross Profit | 88.17 | 86.34 | 85.36 | 86.34 |
| Total Operating Expenses | 40.08 | 41.71 | 41.44 | 41.71 |
| Operating Income | 48.09 | 44.63 | 43.92 | 44.63 |
| Net Income | 37.05 | 33.58 | 33.84 | 33.58 |
| Net Income Attributable to Common Shareholders | 37.05 | 33.58 | 33.84 | 33.58 |
| EPS(USD) | 1.14 | 1.0325 | 1.05 | 1.0325 |
[Company Profile]
Balchem Corporation, incorporated in the State of Maryland in 1967, is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The company's reportable segments are strategic businesses that offer products and services to different markets. The company presently have three reportable segments: Specialty Products; Food, Pharma & Nutrition; and Animal Nutrition & Health. The Company sells its products through its own sales force, independent distributors and sales agents.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet